Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation
Abstract The potential for cardiac implantable electronic device leads to interfere with tricuspid valve (TV) function has gained increasing recognition as having hemodynamic and clinical consequences associated with incremental morbidity and death. The diagnosis and treatment of lead-related (as di...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2017-05, Vol.69 (18), p.2331-2341 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2341 |
|---|---|
| container_issue | 18 |
| container_start_page | 2331 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 69 |
| creator | Chang, James D., MD Manning, Warren J., MD Ebrille, Elisa, MD Zimetbaum, Peter J., MD |
| description | Abstract The potential for cardiac implantable electronic device leads to interfere with tricuspid valve (TV) function has gained increasing recognition as having hemodynamic and clinical consequences associated with incremental morbidity and death. The diagnosis and treatment of lead-related (as distinct from functional) tricuspid regurgitation pose unique challenges. Because of pitfalls in routine diagnostic imaging, a high level of clinical suspicion must be maintained to avoid overlooking the possibility that worsening heart failure is a consequence of mechanical interference with TV leaflet mobility or coaptation and is amenable to lead extraction or valve repair or replacement. The future of cardiac implantable electronic devices includes pacing and perhaps defibrillation without a lead traversing the TV. |
| doi_str_mv | 10.1016/j.jacc.2017.02.055 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1896040687</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109717360382</els_id><sourcerecordid>1896040687</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-1949bf4ef5558aa299ca56c9346010d8b0d896a44116e5b3b1d9c3b7c63fb3c93</originalsourceid><addsrcrecordid>eNp9kUGL1TAUhYM4OM_RP-BCCm7ctN40SduACPLG0YGBGXB04Sak6a2kkzbPpH3y_r0pb1SYxSzCXeQ7h3PPJeQVhYICrd4NxaCNKUqgdQFlAUI8IRsqRJMzIeunZAM1EzkFWZ-S5zEOAFA1VD4jp2XDa0aZ3JAft8GaJe5sl33Xbo_Z-SH2y2Rm66fswjvnf9vpZ3ajDY76DkPmQ7bVobN-j2HGkJ9jb9tgndNz-rocd05Ps17lL8hJr13El_fzjHy7-HS7_ZJfXX--3H68yo3gcs6p5LLtOfYiJde6lNJoURnJeAUUuqZNT1aac0orFC1raScNa2tTsb5liTsjb4--u-B_LRhnNdpoMCWa0C9R0SQHnlavE_rmATr4JUwp3UqlOMDFalgeKRN8jAF7tQt21OGgKKi1eTWotXm1Nq-gVKn5JHp9b720I3b_JH-rTsD7I4Cpi73FoKKxOBnsbEAzq87bx_0_PJAbZydrtLvDA8b_e6iYBOrrevv19LRmFbCmZH8AbWqpdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1895490459</pqid></control><display><type>article</type><title>Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Chang, James D., MD ; Manning, Warren J., MD ; Ebrille, Elisa, MD ; Zimetbaum, Peter J., MD</creator><creatorcontrib>Chang, James D., MD ; Manning, Warren J., MD ; Ebrille, Elisa, MD ; Zimetbaum, Peter J., MD</creatorcontrib><description>Abstract The potential for cardiac implantable electronic device leads to interfere with tricuspid valve (TV) function has gained increasing recognition as having hemodynamic and clinical consequences associated with incremental morbidity and death. The diagnosis and treatment of lead-related (as distinct from functional) tricuspid regurgitation pose unique challenges. Because of pitfalls in routine diagnostic imaging, a high level of clinical suspicion must be maintained to avoid overlooking the possibility that worsening heart failure is a consequence of mechanical interference with TV leaflet mobility or coaptation and is amenable to lead extraction or valve repair or replacement. The future of cardiac implantable electronic devices includes pacing and perhaps defibrillation without a lead traversing the TV.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2017.02.055</identifier><identifier>PMID: 28473139</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Cardiovascular disease ; Cardiovascular diseases ; Congenital diseases ; Defibrillators ; Defibrillators, Implantable - adverse effects ; Device Removal ; Diagnostic systems ; echocardiography ; Electronic devices ; Electronic equipment ; Heart ; Heart diseases ; Heart failure ; Humans ; implantable defibrillators ; Implantation ; Internal Medicine ; Morbidity ; Mortality ; Patients ; Postoperative Complications - etiology ; Regurgitation ; transvenous lead extraction ; Tricuspid valve ; Tricuspid Valve - anatomy & histology ; Tricuspid Valve - physiology ; tricuspid valve insufficiency ; Tricuspid Valve Insufficiency - etiology ; Tricuspid Valve Insufficiency - surgery</subject><ispartof>Journal of the American College of Cardiology, 2017-05, Vol.69 (18), p.2331-2341</ispartof><rights>American College of Cardiology Foundation</rights><rights>2017 American College of Cardiology Foundation</rights><rights>Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited May 9, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-1949bf4ef5558aa299ca56c9346010d8b0d896a44116e5b3b1d9c3b7c63fb3c93</citedby><cites>FETCH-LOGICAL-c549t-1949bf4ef5558aa299ca56c9346010d8b0d896a44116e5b3b1d9c3b7c63fb3c93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109717360382$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28473139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, James D., MD</creatorcontrib><creatorcontrib>Manning, Warren J., MD</creatorcontrib><creatorcontrib>Ebrille, Elisa, MD</creatorcontrib><creatorcontrib>Zimetbaum, Peter J., MD</creatorcontrib><title>Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Abstract The potential for cardiac implantable electronic device leads to interfere with tricuspid valve (TV) function has gained increasing recognition as having hemodynamic and clinical consequences associated with incremental morbidity and death. The diagnosis and treatment of lead-related (as distinct from functional) tricuspid regurgitation pose unique challenges. Because of pitfalls in routine diagnostic imaging, a high level of clinical suspicion must be maintained to avoid overlooking the possibility that worsening heart failure is a consequence of mechanical interference with TV leaflet mobility or coaptation and is amenable to lead extraction or valve repair or replacement. The future of cardiac implantable electronic devices includes pacing and perhaps defibrillation without a lead traversing the TV.</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Congenital diseases</subject><subject>Defibrillators</subject><subject>Defibrillators, Implantable - adverse effects</subject><subject>Device Removal</subject><subject>Diagnostic systems</subject><subject>echocardiography</subject><subject>Electronic devices</subject><subject>Electronic equipment</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Humans</subject><subject>implantable defibrillators</subject><subject>Implantation</subject><subject>Internal Medicine</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Patients</subject><subject>Postoperative Complications - etiology</subject><subject>Regurgitation</subject><subject>transvenous lead extraction</subject><subject>Tricuspid valve</subject><subject>Tricuspid Valve - anatomy & histology</subject><subject>Tricuspid Valve - physiology</subject><subject>tricuspid valve insufficiency</subject><subject>Tricuspid Valve Insufficiency - etiology</subject><subject>Tricuspid Valve Insufficiency - surgery</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUGL1TAUhYM4OM_RP-BCCm7ctN40SduACPLG0YGBGXB04Sak6a2kkzbPpH3y_r0pb1SYxSzCXeQ7h3PPJeQVhYICrd4NxaCNKUqgdQFlAUI8IRsqRJMzIeunZAM1EzkFWZ-S5zEOAFA1VD4jp2XDa0aZ3JAft8GaJe5sl33Xbo_Z-SH2y2Rm66fswjvnf9vpZ3ajDY76DkPmQ7bVobN-j2HGkJ9jb9tgndNz-rocd05Ps17lL8hJr13El_fzjHy7-HS7_ZJfXX--3H68yo3gcs6p5LLtOfYiJde6lNJoURnJeAUUuqZNT1aac0orFC1raScNa2tTsb5liTsjb4--u-B_LRhnNdpoMCWa0C9R0SQHnlavE_rmATr4JUwp3UqlOMDFalgeKRN8jAF7tQt21OGgKKi1eTWotXm1Nq-gVKn5JHp9b720I3b_JH-rTsD7I4Cpi73FoKKxOBnsbEAzq87bx_0_PJAbZydrtLvDA8b_e6iYBOrrevv19LRmFbCmZH8AbWqpdw</recordid><startdate>20170509</startdate><enddate>20170509</enddate><creator>Chang, James D., MD</creator><creator>Manning, Warren J., MD</creator><creator>Ebrille, Elisa, MD</creator><creator>Zimetbaum, Peter J., MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20170509</creationdate><title>Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation</title><author>Chang, James D., MD ; Manning, Warren J., MD ; Ebrille, Elisa, MD ; Zimetbaum, Peter J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-1949bf4ef5558aa299ca56c9346010d8b0d896a44116e5b3b1d9c3b7c63fb3c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Congenital diseases</topic><topic>Defibrillators</topic><topic>Defibrillators, Implantable - adverse effects</topic><topic>Device Removal</topic><topic>Diagnostic systems</topic><topic>echocardiography</topic><topic>Electronic devices</topic><topic>Electronic equipment</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Humans</topic><topic>implantable defibrillators</topic><topic>Implantation</topic><topic>Internal Medicine</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Patients</topic><topic>Postoperative Complications - etiology</topic><topic>Regurgitation</topic><topic>transvenous lead extraction</topic><topic>Tricuspid valve</topic><topic>Tricuspid Valve - anatomy & histology</topic><topic>Tricuspid Valve - physiology</topic><topic>tricuspid valve insufficiency</topic><topic>Tricuspid Valve Insufficiency - etiology</topic><topic>Tricuspid Valve Insufficiency - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, James D., MD</creatorcontrib><creatorcontrib>Manning, Warren J., MD</creatorcontrib><creatorcontrib>Ebrille, Elisa, MD</creatorcontrib><creatorcontrib>Zimetbaum, Peter J., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, James D., MD</au><au>Manning, Warren J., MD</au><au>Ebrille, Elisa, MD</au><au>Zimetbaum, Peter J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2017-05-09</date><risdate>2017</risdate><volume>69</volume><issue>18</issue><spage>2331</spage><epage>2341</epage><pages>2331-2341</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Abstract The potential for cardiac implantable electronic device leads to interfere with tricuspid valve (TV) function has gained increasing recognition as having hemodynamic and clinical consequences associated with incremental morbidity and death. The diagnosis and treatment of lead-related (as distinct from functional) tricuspid regurgitation pose unique challenges. Because of pitfalls in routine diagnostic imaging, a high level of clinical suspicion must be maintained to avoid overlooking the possibility that worsening heart failure is a consequence of mechanical interference with TV leaflet mobility or coaptation and is amenable to lead extraction or valve repair or replacement. The future of cardiac implantable electronic devices includes pacing and perhaps defibrillation without a lead traversing the TV.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28473139</pmid><doi>10.1016/j.jacc.2017.02.055</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2017-05, Vol.69 (18), p.2331-2341 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1896040687 |
| source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Cardiology Cardiovascular Cardiovascular disease Cardiovascular diseases Congenital diseases Defibrillators Defibrillators, Implantable - adverse effects Device Removal Diagnostic systems echocardiography Electronic devices Electronic equipment Heart Heart diseases Heart failure Humans implantable defibrillators Implantation Internal Medicine Morbidity Mortality Patients Postoperative Complications - etiology Regurgitation transvenous lead extraction Tricuspid valve Tricuspid Valve - anatomy & histology Tricuspid Valve - physiology tricuspid valve insufficiency Tricuspid Valve Insufficiency - etiology Tricuspid Valve Insufficiency - surgery |
| title | Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T20%3A39%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tricuspid%20Valve%20Dysfunction%20Following%20Pacemaker%20or%20Cardioverter-Defibrillator%20Implantation&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Chang,%20James%20D.,%20MD&rft.date=2017-05-09&rft.volume=69&rft.issue=18&rft.spage=2331&rft.epage=2341&rft.pages=2331-2341&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2017.02.055&rft_dat=%3Cproquest_cross%3E1896040687%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1895490459&rft_id=info:pmid/28473139&rft_els_id=S0735109717360382&rfr_iscdi=true |